CB Scientific, Inc. (CBSC)
OTCMKTS · Delayed Price · Currency is USD
0.0397
0.00 (0.00%)
May 1, 2025, 2:40 PM EDT

CB Scientific Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2018 FY 2017
Period Ending
Dec '18 Mar '18 Mar '17
Revenue
0.050.040.03
Revenue Growth (YoY)
-11.11%-
Cost of Revenue
0.020.010.02
Gross Profit
0.030.020.02
Selling, General & Admin
0.460.490.37
Other Operating Expenses
0.660.660.02
Operating Expenses
0.781.150.39
Operating Income
-0.75-1.13-0.37
Other Non Operating Income (Expenses)
0.11--0.02
Pretax Income
-0.64-1.13-0.39
Net Income
-0.64-1.13-0.39
Net Income to Common
-0.64-1.13-0.39
Shares Outstanding (Basic)
595857
Shares Outstanding (Diluted)
595857
Shares Change (YoY)
-1.52%-
EPS (Basic)
-0.01-0.02-0.01
EPS (Diluted)
-0.01-0.02-0.01
Free Cash Flow
--0.77-0.06
Free Cash Flow Per Share
--0.01-0.00
Gross Margin
54.34%64.15%49.32%
Operating Margin
-1486.00%-3090.31%-1122.17%
Profit Margin
-1271.68%-3090.31%-1171.49%
Free Cash Flow Margin
--2109.05%-191.28%
EBITDA
--1.13-0.37
D&A For EBITDA
-00
EBIT
-0.75-1.13-0.37
Updated Mar 5, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.